Earlier today, it was announced that Precigen’s PAPZIMEOS (formerly PRGN-2012) was FDA-approved for adults with RRP. Read why ...

But the harsh reality is that very many loss making companies burn through all their cash and go bankrupt. So, the natural question for Plus Therapeutics (NASDAQ:PSTV) shareholders is whether they ...

The fact is that the vast bulk of healthcare expenditures going forward will be connected to chronic illness. Yes, of course, ...

Safety Shot's pivot to hangover-relief drinks and crypto raises doubts amid weak sales and high risks. Read here for an ...

Kolkata: Even with 98% burn injuries, if a victim's multiple dying declarations were consistent and coherent, they alone ...